Metabolic syndrome no guide to CVD risk
Identifying patients with metabolic syndrome will not help in targeting treatment for cardiovascular disease, say researchers.
The findings, from two studies conducted in the UK and the US, dash hopes metabolic syndrome could be used to better identify those patients at greatest risk of cardiovascular events.
The British Regional Heart Study researchers found metabolic syndrome did not improve on Framingham in predicting CVD and CHD risk over 20 years in over 5,100 males.
The other study, in over 4,200 older Americans also found metabolic syndrome was not able to accurately predict total or CVD mortality.
The new studies are published in the International Journal of Obesity and the Archives of Internal Medicine.